Biomarkers of oxidative stress and endothelial dysfunction in glucose intolerance and diabetes mellitus

Clinical Biochemistry

Volumn 41, Issue 18, 2008, Pages 1454-1460

  Pereira, Edimar Cristiano ^a,b   Ferderbar, Simone ^a   Bertolami, Marcelo Chiara ^c   Faludi, André Arpad ^c   Monte, Osmar ^d   Xavier, Hermes Toros ^e   Pereira, Tiago Veiga ^a   Abdalla, Dulcineia Saes Parra ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE MUNICIPAL DE SÃO CAETANO DO SUL   (Brazil)

^c INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^d Fundacao Lusiada Faculdade de Ciencias Medicas de Santos   (Brazil)

^e Santa Casa de Misericordia de Sao Paulo   (Brazil)

Author keywords

Diabetes; Endothelial dysfunction; Glucose intolerance; N acetyl glucosaminidase, Asymmetric dimethylarginine, Homocysteine, Endogenous inhibitors of nitric oxide synthase; Nitric oxide; Nitrotyrosine

Indexed keywords

3 NITROTYROSINE; BIOLOGICAL MARKER; CYSTEINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HOMOCYSTEINE; INSULIN; METHIONINE; N ACETYL BETA GLUCOSAMINIDASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; S NITROSOTHIOL; SYMMETRIC DIMETHYLARGININE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAPILLARY ELECTROPHORESIS; CHEMOLUMINESCENCE; COLORIMETRY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL;

ARGININE; BIOLOGICAL MARKERS; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM; FEMALE; GLUCOSE INTOLERANCE; GLUTATHIONE; HEXOSAMINIDASES; HUMANS; LIPIDS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; OXIDATIVE STRESS;

EID: 55949089360     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.08.074     Document Type: Article

References (49)

1. Pinkney J.H., Stehouwer C.D., Coppack S.W., and Yudkin J.S. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 46 (1997) S9-13
2. Cosentino F., and Lüscher T.F. Endothelial dysfunction in diabetes mellitus. J. Cardiovasc. Pharmacol. 32 (1998) S54-61
3. O'Donnell V.B., Chumley P.H., Hogg N., Bloodsworth A., Darley-Usmar V.M., and Freeman B.A. Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with α-tocopherol. Biochemistry 36 (1997) 15216-15223
4. Hogg N., Darley-Usmar V.M., Wilson M.T., and Moncada S. The oxidation of α-tocoferol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide. Febs. Letters 326 (1993) 199-203
5. Hogg N., Darley-Usmar V.M., Graham A., and Moncada S. Peroxynitrite and atherosclerosis. Biochem. Soc. Trans. 21 (1993) 358-362
6. Augusto O., Gatti R.M., and Radi R. Spin-trapping studies of peroxynitrite decomposition and of 3-morpholinosydnonimine N-ethylcarbamide autooxidation: direct evidence for metal-independent formation of free radical intermediates. Arch. of. Biochem. and. Biophys. 310 (1994) 118-125
7. Balint B., Kharitonov S.A., Hanazawa T., Donnelly L.E., Shah P.L., Hodson M.E., and Barnes P.J. Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis. Eur. Respir. J. 17 (2001) 1201-1207
8. Moshage H., Kok B., Huizenga J.R., and Jansen P.L. Nitrite and nitrate determination in plasma: a critical evaluation. Clin. Chem. 41 (1995) 892-896
9. Wennmalm A. A new face of atherosclerosis. New discoveries about the role of nitric oxide result in complementary therapy methods. Lakartidningen 91 (1994) 843-847
10. Kelm M., Schäfer S., Dahmann R., et al. Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation. Cardiovasc. Res. 36 (1997) 185-194
11. Stamler J.S., Singel D.J., and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 18 (1992) 1898-1902
12. Cooke J.P., and Dzau V.J. Derangements of the nitric oxide synthase pathway,l-arginine, and cardiovascular disease. Circulation 96 (1997) 379-382
13. Fard A., Tuck C.H., Donis J.A., et al. Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2039-2044
14. Hoogeveen E.K., Kostense P.J., Jakobs C., et al. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. Circulation 101 (2000) 1506-1511
15. Bar-On H., Kidron M., Friedlander Y., et al. Plasma total homocysteine levels in subjects with hyperinsulinemia. J. Intern. Med. 247 (2000) 287-294
16. Hayes L.W., Goguen C.A., Stevens A.L., Magargal W.W., and Slakey L.L. Enzyme activities in endothelial cells and smooth muscle cells from swine aorta. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 2532-2535
17. Inoue T., Matsunaga R., Morooka S., and Uehara Y. Serum N-acetyl-β-d-glucosaminidase activity increases in association with insulin resistance in patients with coronary artery disease. Atherosclerosis 149 (2000) 117-122
18. Ikenaga H., Suzuki H., Ishii N., Itoh H., and Saruta T. Enzymuria in non-insulin-dependent patients: signs of tubular cell dysfunction. Clin. Sci. 84 (1993) 469-475
19. Yamada E., Hazama F., Amano S., Sasahara M., Kataoka H., and Kayembe K. Semiquantitative histochemical investigation of lysosomal enzyme activities in the aortic endothelial cells of spontaneously hypertensive rats. Atherosclerosis 47 (1983) 19-26
20. Gabir M.M., Hanson R.L., Dabelea D., Imperatore G., Roumain J., Bennett P.H., and Knowler W.C. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23 (2000) 1108-1112
21. Reglero A., and Cabezas J.A. Glycosidases of molluscs. Purification and properties of alpha-l-fucosidase from Chamelea gallina L. Eur. J. Biochem. 66 (1976) 379-387
22. Ewing J.F., and Janero D.R. Specific S-nitrosothiol (thionitrite) quantification as solution nitrite after vanadium (III) reduction and ozone-chemiluminescent detection. Free. Radic. Biol. Med. 25 (1998) 621-628
23. Marley R., Feelisch M., Holt S., and Moore K.A. A chemiluminescense-based assay for S-nitrosoalbumin and other plasma S-nitrosothiols. Free. Radic. Res. 32 (2000) 1-9
24. Caussé E., Siri N., and Arnal J.F. Determination of asymmetrical dimethylarginine by capillary electrophoresis-laser-induced fluorescence. J. Chromatogr. B. Biomed. Sci. Appl. 741 (2000) 77-83
25. Vecchione G., Margaglione M., Grandone E., et al. Determining sulfur-containing amino acids by capillary electrophoresis: a fast novel method for total homocyst(e)ine human plasma. Electrophoresis 20 (1999) 569-574
26. Chakmakjian G.J. Endocrinology. In: Race G.J. (Ed). Laboratory medicine (1982), Haper and Row, Philadelphia, MD 1-3
27. Farkas J., and Menzel E.J. Proteins lose their nitric oxide stabilizing function after advanced glycosylation. Biochim. Biophys. Acta. 1245 (1995) 305-310
28. Johansen J.S., Harris A.K., Rychly A.J., and Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc. Diabetol. 4 (2005) 1-11
29. Bardell A.L., and Macleod K.M. Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats. J. Pharmacol. Exp. Ther. 296 (2001) 252-259
30. Ceriello A., Quagliaro L., and Catone B. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care, 25 (2002) 1439-1443
31. Konukoglu D., Dogan E., Turhan M.S., and Husrev H.H. Impaired glucose tolerance: its relevance to early endothelial dysfunction. Horm. Metab. Res. 35 (2003) 607-610
32. Nomiyama T., and Igarashi Y. Taka T-stimulated glucose uptake by peroxynitrite is concurrent with tyrosine nitration of insulin receptor subtrate-1. Biochem. and. Biophys. Res. Commun. 320 (2004) 639-647
33. Turko I.V., Li L., Aulak K.S., Stuehr D.J., Chang J.Y., and Murad F. Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes. J. Biol. Chem. 278 (2003) 33972-33977
34. G-dimethylarginine in the rabbit. Biochem. J. 154 (1976) 179-184
35. Xiong Y., Lei M., Fu S., and Fu Y. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes. Life Sci. 77 (2005) 149-159
36. Miyazaki H., Matsuoka H., Cooke J.P., et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 99 (1999) 1141-1146
37. Chan J.R., Böger R.H., Bode-Böger S.M., et al. Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1040-1046
38. Wolff S.P., and Dean R.T. Glucose autoxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes. Biochem. J. 245 (1987) 243-250
39. Ferderbar S., Pereira E.C., Apolinário E., et al. Cholesterol oxides as biomarkers of oxidative stress in type 1 and diabetes mellitus type 2. Diabetes Metab. Res. Rev. 23 (2007) 35-42
40. Böger R.H., Sydow K., Borlak J., et al. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells - involvement of S-adenosylmethionine-dependent methyltransferases. Cir. Res. 87 (2000) 99-105
41. Elias A.N., and Eng S. Homocysteine concentrations in patients with diabetes mellitus - relationship to microvascular and macrovascular disease. Diabetes Obes. Metab. 7 (2005) 117-121
42. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005) 1615-1625
43. Cameron N.E., Cotter M.A., Basso M., and Hohman T.C. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 40 (1997) 271-281
44. Skrha J., Prázný M., Hilgertoá J., and Weiseroá H. Serum alpha-tocopherol and ascorbic acid concentrations in type 1 and type 2 diabetic patients with and without angiopathy. Clin. Chim. Acta 329 (2003) 103-108
45. Sánchez-Hueso M.C., Mateo-Caãs J., and Zamora-Madaria E. Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes. An. Med. Interna. 12 (1995) 216-220
46. Skrha J., Prázný M., Haas T., Kvasnicka J., and Kalvodová B. Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in type 1 diabetic patients. J. Diabetes. Complications 15 (2001) 234-240
47. Skrha J., Prázný M., Kvasnicka J., and Kalvodová B. Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy. Cas. Lek. Cesk. 140 (2001) 370-374
48. Skrha J., Perusicová J., Stolba P., Stibor V., and Páv J. Comparison of N-acetyl-β-glucosaminidase and albuminuria with clinical finding of microangiopathy in type I diabetes mellitus. Clin. Chim. Acta. 166 (1987) 135-141
49. Komosinska-Vassev K., Olczyk K., Kozma E.M., Olczyk P., Wisowski G., and Winsz-Szczotka K. Alterations of glycosaminoglycan metabolism in the development of diabetic complications in relation to metabolic control. Clin. Chem. Lab. Med. 43 (2005) 924-929